-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Cut to $300.00/Share From $400.00 by Morgan Stanley

Dow Jones·07/31/2026 17:25:00

Please log in to view news